These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 2969083
21. Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Hutson PH, Dourish CT, Curzon G. Eur J Pharmacol; 1986 Oct 07; 129(3):347-52. PubMed ID: 2430815 [Abstract] [Full Text] [Related]
22. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Andersen HL, Kilpatrick IC. Br J Pharmacol; 1996 May 07; 118(2):421-7. PubMed ID: 8735647 [Abstract] [Full Text] [Related]
23. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor. Tricklebank MD, Neill J, Kidd EJ, Fozard JR. Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789 [Abstract] [Full Text] [Related]
24. Stimulation of median, but not dorsal, raphe 5-HT1A autoreceptors by the local application of 8-OH-DPAT reverses raclopride-induced catalepsy in the rat. Wadenberg ML, Hillegaart V. Neuropharmacology; 1995 May 06; 34(5):495-9. PubMed ID: 7566483 [Abstract] [Full Text] [Related]
25. Destruction of the nucleus raphe obscurus and potentiation of serotonin-mediated behaviors following administration of the neurotoxin 3-acetylpyridine. Wieland S, Kreider MS, McGonigle P, Lucki I. Brain Res; 1990 Jun 18; 520(1-2):291-302. PubMed ID: 1698505 [Abstract] [Full Text] [Related]
26. Acute administration of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective 5-HT-receptor agonist, causes a biphasic blood pressure response and a bradycardia in the normotensive Sprague-Dawley rat and in the spontaneously hypertensive rat. Gradin K, Pettersson A, Hedner T, Persson B. J Neural Transm; 1985 Jun 18; 62(3-4):305-19. PubMed ID: 3161997 [Abstract] [Full Text] [Related]
27. Effect of chronic treatment with 8-OH-DPAT in the forced swimming test requires the integrity of presynaptic serotonergic mechanisms. Cervo L, Samanin R. Psychopharmacology (Berl); 1991 Jun 18; 103(4):524-8. PubMed ID: 1829537 [Abstract] [Full Text] [Related]
28. Cardiovascular effects of 5-HT1A receptor agonists injected into the dorsal raphe nucleus of conscious rats. Connor HE, Higgins GA. Eur J Pharmacol; 1990 Jun 21; 182(1):63-72. PubMed ID: 2144824 [Abstract] [Full Text] [Related]
30. Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine-lesioned rats. Gerber R, Altar CA, Liebman JM. Psychopharmacology (Berl); 1988 Apr 21; 94(2):178-82. PubMed ID: 2965396 [Abstract] [Full Text] [Related]
31. Effects of 5-HT and 8-OH-DPAT on forebrain monoamine synthesis after local application into the median and dorsal raphe nuclei of the rat. Hillegaart V, Hjorth S, Ahlenius S. J Neural Transm Gen Sect; 1990 Apr 21; 81(2):131-45. PubMed ID: 2141990 [Abstract] [Full Text] [Related]
32. 8-Hydroxy-2-(di-n-propylamino)tetralin, a 5-HT1A receptor agonist, impairs performance in a passive avoidance task. Carli M, Tranchina S, Samanin R. Eur J Pharmacol; 1992 Feb 11; 211(2):227-34. PubMed ID: 1535320 [Abstract] [Full Text] [Related]
33. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia. Bill DJ, Knight M, Forster EA, Fletcher A. Br J Pharmacol; 1991 Aug 11; 103(4):1857-64. PubMed ID: 1833017 [Abstract] [Full Text] [Related]
34. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat. Przegaliński E, Budziszewska B, Warchoł-Kania A, Błaszczyńska E. Pharmacol Biochem Behav; 1989 Jun 11; 33(2):329-34. PubMed ID: 2530590 [Abstract] [Full Text] [Related]
35. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Schreiber R, De Vry J. Eur J Pharmacol; 1993 Nov 16; 249(3):341-51. PubMed ID: 7904566 [Abstract] [Full Text] [Related]
36. Anticataleptic 8-OH-DPAT preferentially counteracts with haloperidol-induced Fos expression in the dorsolateral striatum and the core region of the nucleus accumbens. Ohno Y, Shimizu S, Imaki J, Ishihara S, Sofue N, Sasa M, Kawai Y. Neuropharmacology; 2008 Oct 16; 55(5):717-23. PubMed ID: 18585397 [Abstract] [Full Text] [Related]
37. 8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Dourish CT, Hutson PH, Kennett GA, Curzon G. Appetite; 1986 Oct 16; 7 Suppl():127-40. PubMed ID: 2943219 [Abstract] [Full Text] [Related]
38. Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Hutson PH, Sarna GS, O'Connell MT, Curzon G. Neurosci Lett; 1989 May 22; 100(1-3):276-80. PubMed ID: 2474776 [Abstract] [Full Text] [Related]
39. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat. Tricklebank MD, Forler C, Fozard JR. Eur J Pharmacol; 1984 Nov 13; 106(2):271-82. PubMed ID: 6241568 [Abstract] [Full Text] [Related]
40. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat. Hillegaart V. Physiol Behav; 1990 Jul 13; 48(1):143-8. PubMed ID: 2146690 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]